2023-08-012024-07-312024-07-31false08601140Krypa Medical Care Ltd2024-11-2586220iso4217:GBPxbrli:pure086011402023-08-01086011402024-07-31086011402023-08-012024-07-31086011402022-08-01086011402023-07-31086011402022-08-012023-07-3108601140bus:SmallEntities2023-08-012024-07-3108601140bus:AuditExempt-NoAccountantsReport2023-08-012024-07-3108601140bus:FullAccounts2023-08-012024-07-3108601140bus:PrivateLimitedCompanyLtd2023-08-012024-07-3108601140core:WithinOneYear2024-07-3108601140core:AfterOneYear2024-07-3108601140core:WithinOneYear2023-07-3108601140core:AfterOneYear2023-07-3108601140core:ShareCapital2024-07-3108601140core:SharePremium2024-07-3108601140core:RevaluationReserve2024-07-3108601140core:OtherReservesSubtotal2024-07-3108601140core:RetainedEarningsAccumulatedLosses2024-07-3108601140core:ShareCapital2023-07-3108601140core:SharePremium2023-07-3108601140core:RevaluationReserve2023-07-3108601140core:OtherReservesSubtotal2023-07-3108601140core:RetainedEarningsAccumulatedLosses2023-07-3108601140core:LandBuildings2024-07-3108601140core:PlantMachinery2024-07-3108601140core:Vehicles2024-07-3108601140core:FurnitureFittings2024-07-3108601140core:OfficeEquipment2024-07-3108601140core:NetGoodwill2024-07-3108601140core:IntangibleAssetsOtherThanGoodwill2024-07-3108601140core:ListedExchangeTraded2024-07-3108601140core:UnlistedNon-exchangeTraded2024-07-3108601140core:LandBuildings2023-07-3108601140core:PlantMachinery2023-07-3108601140core:Vehicles2023-07-3108601140core:FurnitureFittings2023-07-3108601140core:OfficeEquipment2023-07-3108601140core:NetGoodwill2023-07-3108601140core:IntangibleAssetsOtherThanGoodwill2023-07-3108601140core:ListedExchangeTraded2023-07-3108601140core:UnlistedNon-exchangeTraded2023-07-3108601140core:LandBuildings2023-08-012024-07-3108601140core:PlantMachinery2023-08-012024-07-3108601140core:Vehicles2023-08-012024-07-3108601140core:FurnitureFittings2023-08-012024-07-3108601140core:OfficeEquipment2023-08-012024-07-3108601140core:NetGoodwill2023-08-012024-07-3108601140core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3108601140core:ListedExchangeTraded2023-08-012024-07-3108601140core:UnlistedNon-exchangeTraded2023-08-012024-07-3108601140core:MoreThanFiveYears2023-08-012024-07-3108601140core:Non-currentFinancialInstruments2024-07-3108601140core:Non-currentFinancialInstruments2023-07-3108601140dpl:CostSales2023-08-012024-07-3108601140dpl:DistributionCosts2023-08-012024-07-3108601140core:LandBuildings2023-08-012024-07-3108601140core:PlantMachinery2023-08-012024-07-3108601140core:Vehicles2023-08-012024-07-3108601140core:FurnitureFittings2023-08-012024-07-3108601140core:OfficeEquipment2023-08-012024-07-3108601140dpl:AdministrativeExpenses2023-08-012024-07-3108601140core:NetGoodwill2023-08-012024-07-3108601140core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3108601140dpl:GroupUndertakings2023-08-012024-07-3108601140dpl:ParticipatingInterests2023-08-012024-07-3108601140dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3108601140core:ListedExchangeTraded2023-08-012024-07-3108601140dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3108601140core:UnlistedNon-exchangeTraded2023-08-012024-07-3108601140dpl:CostSales2022-08-012023-07-3108601140dpl:DistributionCosts2022-08-012023-07-3108601140core:LandBuildings2022-08-012023-07-3108601140core:PlantMachinery2022-08-012023-07-3108601140core:Vehicles2022-08-012023-07-3108601140core:FurnitureFittings2022-08-012023-07-3108601140core:OfficeEquipment2022-08-012023-07-3108601140dpl:AdministrativeExpenses2022-08-012023-07-3108601140core:NetGoodwill2022-08-012023-07-3108601140core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3108601140dpl:GroupUndertakings2022-08-012023-07-3108601140dpl:ParticipatingInterests2022-08-012023-07-3108601140dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-012023-07-3108601140core:ListedExchangeTraded2022-08-012023-07-3108601140dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-012023-07-3108601140core:UnlistedNon-exchangeTraded2022-08-012023-07-3108601140core:NetGoodwill2024-07-3108601140core:IntangibleAssetsOtherThanGoodwill2024-07-3108601140core:LandBuildings2024-07-3108601140core:PlantMachinery2024-07-3108601140core:Vehicles2024-07-3108601140core:FurnitureFittings2024-07-3108601140core:OfficeEquipment2024-07-3108601140core:AfterOneYear2024-07-3108601140core:WithinOneYear2024-07-3108601140core:ListedExchangeTraded2024-07-3108601140core:UnlistedNon-exchangeTraded2024-07-3108601140core:ShareCapital2024-07-3108601140core:SharePremium2024-07-3108601140core:RevaluationReserve2024-07-3108601140core:OtherReservesSubtotal2024-07-3108601140core:RetainedEarningsAccumulatedLosses2024-07-3108601140core:NetGoodwill2023-07-3108601140core:IntangibleAssetsOtherThanGoodwill2023-07-3108601140core:LandBuildings2023-07-3108601140core:PlantMachinery2023-07-3108601140core:Vehicles2023-07-3108601140core:FurnitureFittings2023-07-3108601140core:OfficeEquipment2023-07-3108601140core:AfterOneYear2023-07-3108601140core:WithinOneYear2023-07-3108601140core:ListedExchangeTraded2023-07-3108601140core:UnlistedNon-exchangeTraded2023-07-3108601140core:ShareCapital2023-07-3108601140core:SharePremium2023-07-3108601140core:RevaluationReserve2023-07-3108601140core:OtherReservesSubtotal2023-07-3108601140core:RetainedEarningsAccumulatedLosses2023-07-3108601140core:NetGoodwill2022-08-0108601140core:IntangibleAssetsOtherThanGoodwill2022-08-0108601140core:LandBuildings2022-08-0108601140core:PlantMachinery2022-08-0108601140core:Vehicles2022-08-0108601140core:FurnitureFittings2022-08-0108601140core:OfficeEquipment2022-08-0108601140core:AfterOneYear2022-08-0108601140core:WithinOneYear2022-08-0108601140core:ListedExchangeTraded2022-08-0108601140core:UnlistedNon-exchangeTraded2022-08-0108601140core:ShareCapital2022-08-0108601140core:SharePremium2022-08-0108601140core:RevaluationReserve2022-08-0108601140core:OtherReservesSubtotal2022-08-0108601140core:RetainedEarningsAccumulatedLosses2022-08-0108601140core:AfterOneYear2023-08-012024-07-3108601140core:WithinOneYear2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:CostValuation2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3108601140core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3108601140core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3108601140core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3108601140core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3108601140core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3108601140core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3108601140core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3108601140core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3108601140core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3108601140core:Non-currentFinancialInstrumentscore:CostValuation2023-07-3108601140core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-3108601140core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-3108601140core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-3108601140core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-3108601140core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-3108601140core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-3108601140core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-3108601140core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-3108601140bus:Director12023-08-012024-07-3108601140bus:Director22023-08-012024-07-3108601140bus:Director32023-08-012024-07-31

Krypa Medical Care Ltd

Registered Number
08601140
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2024

Krypa Medical Care Ltd
Company Information
for the year from 1 August 2023 to 31 July 2024

Directors

Anil Kumar Hemandas Rochiramani
Krishna Rochiramani
Paras Rochiramani

Company Secretary

Krishna Rochiramani

Registered Address

Whiteleaf Business Centre
11 Little Balmer
Buckingham
MK18 1TF

Registered Number

08601140 (England and Wales)
Krypa Medical Care Ltd
Balance Sheet as at
31 July 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3121,66094,105
121,66094,105
Current assets
Cash at bank and on hand68,08044,760
68,08044,760
Creditors amounts falling due within one year4(18,752)(57,499)
Net current assets (liabilities)49,328(12,739)
Total assets less current liabilities170,98881,366
Creditors amounts falling due after one year5(73,858)(44,962)
Net assets97,13036,404
Capital and reserves
Called up share capital200200
Profit and loss account96,93036,204
Shareholders' funds97,13036,404
The financial statements were approved and authorised for issue by the Board of Directors on 25 November 2024, and are signed on its behalf by:
Anil Kumar Hemandas Rochiramani
Director
Registered Company No. 08601140
Krypa Medical Care Ltd
Notes to the Financial Statements
for the year ended 31 July 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
2.Average number of employees

20242023
Average number of employees during the year33
3.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 August 231,841143,86921,693167,403
Additions1,61446,40926,88174,904
Disposals-(79,439)(3,629)(83,068)
At 31 July 243,455110,83944,945159,239
Depreciation and impairment
At 01 August 2346067,7045,13473,298
Charge for year79337,7777,77946,349
On disposals-(78,439)(3,629)(82,068)
At 31 July 241,25327,0429,28437,579
Net book value
At 31 July 242,20283,79735,661121,660
At 31 July 231,38176,16516,55994,105
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security339-
Finance lease and HP contracts12,62945,989
Other creditors5,78411,457
Accrued liabilities and deferred income-53
Total18,75257,499
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Creditors: amounts due after one year

2024

2023

££
Other creditors73,85844,962
Total73,85844,962
6.Obligations under finance leases

2024

2023

££
Finance lease and HP contracts73,85844,962